文献速递心境障碍

右侧单侧超短脉冲电休克与磁惊厥治疗双相抑郁的临床与认知结局比较:CORRECT-BD试验

Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial.
PubMed 文献 · Am J Psychiatry · 2026-05-06

该双盲随机平行组预试验比较右侧单侧超短脉冲电休克(RUL-UB ECT)与磁惊厥治疗(MST)在双相抑郁患者中的疗效与认知不良反应。55例随机分组,45例完成充分治疗,ECT组6/20(30%)与MST组5/25(20%)达到临床缓解;自传体记忆临床重要恶化在ECT组为6/27(22.2%),MST组为2/28(7.1%)。两组抑郁症状改善相似,MST认知不良反应更少且耐受性更好,但样本量小,结果属初步。

要点

  • MST与RUL-UB ECT对双相抑郁症状改善相似。
  • MST组自传体记忆临床重要恶化比例低于ECT组。
  • MST耐受性更好,但样本量小,结论属初步。

核心结论

  • MST与RUL-UB ECT对双相抑郁症状改善相似。
  • MST自传体记忆恶化更少且耐受性更好,可能为安全临床应用。
  • 样本量较小,结果应视为初步。

研究设计与样本

  • 双盲、随机、平行组预试验临床研究。
  • 双相抑郁患者随机接受RUL-UB ECT或MST,直至缓解、脱落或最多21次治疗。
  • 主要结局为24项汉密尔顿抑郁量表评估的临床缓解与自传体记忆测验评估的认知不良反应。
  • 55例随机分组,45例接受充分治疗。

主要发现

  • ECT组6/20(30%)与MST组5/25(20%)达到临床缓解。
  • 自传体记忆临床重要恶化(AMT评分下降≥25%)在ECT组为6/27(22.2%),MST组为2/28(7.1%)。
  • 两组次要临床结局相似。

关键数值与推荐

  • 临床缓解采用24项汉密尔顿抑郁量表评估。
  • 认知不良反应采用自传体记忆测验评估,临床重要恶化定义为AMT评分下降≥25%。
  • 治疗上限为最多21次。

临床怎么用

  • 对双相抑郁患者,MST可能作为认知不良反应更少的替代选择。
  • 临床决策时需结合认知不良反应风险与初步证据级别。

局限性

  • 预试验样本量相对较小。
  • 结果应视为初步,需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Despite the established clinical effectiveness of electroconvulsive therapy (ECT) in the treatment of bipolar depression, its acceptance is limited by concerns over cognitive adverse effects. Magnetic seizure therapy (MST) has shown promise in treating patients with depression, with fewer cognitive adverse effects. The aim of this pilot study was to assess the clinical efficacy and cognitive adverse effects of MST compared to right unilateral ultrabrief-pulse (RUL-UB) ECT in patients with bipolar depression. METHODS: In this double-blind, randomized, parallel-group pilot clinical trial, participants with bipolar depression received either RUL-UB ECT or MST until they achieved remission, dropped out, or received a maximum of 21 treatments. The primary outcomes were 1) clinical remission as assessed with the 24-item Hamilton Rating Scale for Depression and 2) cognitive adverse effects as assessed with the Autobiographical Memory Test (AMT). RESULTS: Of 55 participants who were randomized, 45 received an adequate trial of treatment, of whom 6/20 (30%) in the ECT group and 5/25 (20%) in the MST group achieved remission. Clinically important worsening in autobiographical memory (≥25% decline in AMT score) occurred in 6/27 (22.2%) participants in the ECT group and 2/28 (7.1%) in the MST group. Secondary clinical outcomes were similar in both groups. CONCLUSIONS: This pilot study demonstrated similar effects on depression symptoms between MST and ECT. MST appeared to have resulted in less worsening of autobiographical memory and was better tolerated, suggesting that it may be a safe clinical application to treat bipolar depression. Given the relatively small sample size of this pilot study, these findings should be considered preliminary.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Blumberger DM, Vila Rodriguez F, McClintock SM, et al. Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial. Am J Psychiatry. 2026. PMID: 42087328. doi:10.1176/appi.ajp.20250955

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。